Rational Down syndrome screening policy.
作者信息
Cuckle H
机构信息
University of Leeds, England.
出版信息
Am J Public Health. 1998 Apr;88(4):558-9. doi: 10.2105/ajph.88.4.558.
Abstract
摘要
相似文献
1
Rational Down syndrome screening policy.合理的唐氏综合征筛查政策。
Am J Public Health. 1998 Apr;88(4):558-9. doi: 10.2105/ajph.88.4.558.
2
Trade-offs in prenatal detection of Down syndrome.唐氏综合征产前检测中的权衡
Am J Public Health. 1998 Apr;88(4):551-7. doi: 10.2105/ajph.88.4.551.
3
The variation of risk estimates through pregnancy in second trimester maternal serum screening for Down syndrome.孕中期孕妇血清唐氏综合征筛查中风险评估随孕周的变化。
Prenat Diagn. 2002 May;22(5):385-7. doi: 10.1002/pd.297.
4
Down syndrome prevention program in a population with an older maternal age.
Obstet Gynecol. 1995 Mar;85(3):368-73. doi: 10.1016/0029-7844(94)00401-X.
5
Serum screening for Down's syndrome.
Midwives (1995). 1995 Jul;108(1290):207-10.
6
Prenatal screening for Down's syndrome--a search for the family's values.唐氏综合征的产前筛查——探寻家庭价值观。
N Engl J Med. 1999 Aug 12;341(7):521-2. doi: 10.1056/NEJM199908123410709.
7
The triple test decision.
Mod Midwife. 1996 Aug;6(8):16-9.
8
Ethical concerns and future directions in maternal screening for Down syndrome.
Womens Health Issues. 1995 Spring;5(1):15-20. doi: 10.1016/1049-3867(94)00055-U.
9
[Maternal serum screening for detection of fetal chromosome abnormalities].
Gynakologe. 1995 Oct;28(5):280-8.
10
Prevention of Down syndrome: the Jerusalem experience.唐氏综合征的预防：耶路撒冷的经验。
Isr J Med Sci. 1993 Aug;29(8):468-70.
本文引用的文献
1
Trade-offs in prenatal detection of Down syndrome.唐氏综合征产前检测中的权衡
Am J Public Health. 1998 Apr;88(4):551-7. doi: 10.2105/ajph.88.4.551.
2
Fetal nuchal translucency test for Down's syndrome.
Lancet. 1997 Nov 29;350(9091):1629-30; author reply 1631-2. doi: 10.1016/s0140-6736(05)64047-0.
3
Second-trimester dimeric inhibin-A in Down's syndrome screening.孕中期二聚体抑制素A用于唐氏综合征筛查。
Prenat Diagn. 1996 Dec;16(12):1101-10. doi: 10.1002/(SICI)1097-0223(199612)16:12<1101::AID-PD5>3.0.CO;2-7.
4
Combining inhibin A with existing second-trimester markers in maternal serum screening for Down's syndrome.在孕中期唐氏综合征血清筛查中，将抑制素A与现有标志物相结合。
Prenat Diagn. 1996 Dec;16(12):1095-100. doi: 10.1002/(SICI)1097-0223(199612)16:12<1095::AID-PD997>3.0.CO;2-9.
5
Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation.通过孕妇年龄和孕10至14周时胎儿颈部透明带厚度筛查胎儿三体综合征。
Br J Obstet Gynaecol. 1995 Dec;102(12):957-62. doi: 10.1111/j.1471-0528.1995.tb10902.x.
6
Improved parameters for risk estimation in Down's syndrome screening.唐氏综合征筛查中风险评估的改进参数。
Prenat Diagn. 1995 Nov;15(11):1057-65. doi: 10.1002/pd.1970151111.
7
Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level.利用女性年龄和血清甲胎蛋白水平估算其怀有唐氏综合征相关妊娠的风险。
Br J Obstet Gynaecol. 1987 May;94(5):387-402. doi: 10.1111/j.1471-0528.1987.tb03115.x.
8
Model-based screening by risk with application to Down's syndrome.
Stat Med. 1992 Jan 30;11(2):257-68. doi: 10.1002/sim.4780110211.
9
Measuring unconjugated estriol in maternal serum to screen for fetal down syndrome.
Clin Chem. 1992 Sep;38(9):1687-9.
10
Maternal serum screening for Down's syndrome: the effect of routine ultrasound scan determination of gestational age and adjustment for maternal weight.唐氏综合征的母体血清筛查：常规超声扫描确定孕周及根据母体体重进行校正的影响。
Br J Obstet Gynaecol. 1992 Feb;99(2):144-9. doi: 10.1111/j.1471-0528.1992.tb14474.x.
Zotero 插件